Facial Plast Surg 2010; 26(4): 310-319
DOI: 10.1055/s-0030-1262315
© Thieme Medical Publishers

FILLERS-Q: An Instrument for Assessing Patient Experiences after Treatment with Facial Injectable Soft Tissue Fillers

Anthony P. Sclafani1 , Laura Pizzi3 , Eric Jutkowitz3 , Nancy Mueller3 , Matthew Jung2
  • 1Division of Facial Plastic Surgery, Department of Otolaryngology, The New York Eye and Ear Infirmary, New York, New York
  • 2Department of Otolaryngology, New York Medical College, Valhalla, New York
  • 3Doris N. Grandon Center for Health Economics and Outcomes Research, Jefferson School of Population Health, Philadelphia, Pennsylvania
Further Information

Publication History

Publication Date:
27 July 2010 (online)

ABSTRACT

Patient-reported outcomes data are limited after injectable soft tissue filler treatment. Patient-reported outcome measures (PROMs) are becoming integral to medical practices in other specialties and will become so as well in facial plastic surgery. The obvious differences in types of disorders treated and the outcomes of primary importance seen between general medical/surgical and facial plastic surgery practices make institution of standard outcomes studies difficult in facial plastic surgery. However, understanding the patient's experience and satisfaction with treatment is essential to continue to provide excellent care to facial aesthetic patients. This article describes use of a new survey instrument, Facial Injectables: Longevity, Late and Early Reactions and Satisfaction Questionnaire (FILLERS-Q), in assessing patient response to facial injections of soft tissue fillers. FILLERS-Q is a 43-item questionnaire that captures patient demographics (4 items), patient satisfaction with treatment (10 items), procedure-related events (3 to 7 items), impact on relationships (9 to 15 items), and economic considerations related to dermal filler treatment (3 to 7 items). The results provide a “snapshot” of patients treated in an individual surgeon's practice.

REFERENCES

  • 1 American Society of Aesthetic Plastic Surgery .Cosmetic Surgery National Data Bank Statistics, 2009. Available at: http://asaps.org/sites/default/files/2009stats.pdf Accessed April 17, 2010
  • 2 Sclafani A P, Fagien S. Treatment of injectable soft tissue filler complications.  Dermatol Surg. 2009;  35(Suppl 2) 1672-1680
  • 3 Kosowski T R, McCarthy C, Reavey P L et al.. A systematic review of patient-reported outcome measures after facial cosmetic surgery and/or nonsurgical facial rejuvenation.  Plast Reconstr Surg. 2009;  123 1819-1827
  • 4 Lupo M P, Smith S R, Thomas J A, Murphy D K, Beddingfield III F C. Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds.  Plast Reconstr Surg. 2008;  121 289-297
  • 5 Narins R S, Brandt F S, Lorenc Z P et al.. A randomized, multicenter study of the safety and efficacy of Dermicol-P35 and non-animal-stabilized hyaluronic acid gel for the correction of nasolabial folds.  Dermatol Surg. 2007;  33(Suppl 2) S213-S221; discussion S221
  • 6 Narins R S, Brandt F, Leyden J, Lorenc Z P, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds.  Dermatol Surg. 2003;  29 588-595
  • 7 Moers-Carpi M, Vogt S, Santos B M, Planas J, Vallve S R, Howell D J. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds.  Dermatol Surg. 2007;  33(Suppl 2) S144-S151
  • 8 Carruthers A, Carey W, De Lorenzi C, Remington K, Schachter D, Sapra S. Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, restylane perlane and hylaform, in the treatment of nasolabial folds.  Dermatol Surg. 2005;  31(11 Pt 2) 1591-1598 discussion 1598
  • 9 Cohen S R, Berner C F, Busso M et al.. ArteFill: a long-lasting injectable wrinkle filler material—summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes.  Plast Reconstr Surg. 2006;  118(3, Suppl) 64S-76S
  • 10 Rossner F, Rossner M, Hartmann V, Erdmann R, Wiest L G, Rzany B. Decrease of reported adverse events to injectable polylactic acid after recommending an increased dilution: 8-year results from the Injectable Filler Safety study.  J Cosmet Dermatol. 2009;  8 14-18

Anthony P SclafaniM.D. F.A.C.S. 

Division of Facial Plastic Surgery, Department of Otolaryngology, The New York Eye & Ear Infirmary

310 East 14th Street, Sixth Floor, North Building, New York, NY 10003

Email: asclafani@nyee.edu

    >